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In the past decade, fluctuations in numbers of import-
ed malaria cases have been seen in Canada. In 1997 to
1998, malaria case numbers more than doubled before
returning to normal. This increase was not seen in any
other industrialized country. The Canadian federal malaria
surveillance system collects insufficient data to interpret
these fluctuations. Using local (sentinel), provincial, feder-
al, and international malaria surveillance data, we evaluate
and interpret these fluctuations. Several epidemics are
described. With an ever-increasing immigrant and refugee
population of tropical origin, improved surveillance will be
necessary to guide public health prevention policy and
practice. The Canadian experience is likely to be general-
izable to other industrialized countries where malaria is a
reportable disease within a passive surveillance system.
M
alaria has been a reportable communicable disease in
Canada since 1929, when a surveillance system for
communicable diseases was first developed. Although no
longer endemic in Canada, malaria has remained an impor-
tant imported disease, principally in immigrants and travel-
ers (1–3). Rarely, it has been transmitted in blood products
(4). Published reports document delays in clinical and lab-
oratory diagnoses of malaria and lack of understanding of
malaria prophylaxis and fever management in travelers (3).
The Canadian infectious disease surveillance system has
reported an average of 538 malaria cases per year since
1990, and Statistics Canada reported an average of one
death per year (5,6, Carole Scott [Division of Disease
Surveillance, Health Canada], pers. comm.). The present
federal surveillance system reports the age and sex of a
patient and does not document malaria death rate, malaria
species, nor the likely country of acquisition. While malar-
ia-related deaths may be few, that any exist is a matter of
concern. The continued incidence of malaria cases and
deaths in Canada suggests that the malaria surveillance sys-
tem should be strengthened and used more proactively to
help identify appropriate preventive measures.
All 10 provincial and 3 territorial health authorities in
Canada are required by law to report diagnoses of malaria
and other selected diseases to federal authorities at Health
Canada (2). Summary reports of these diseases are pub-
lished by both levels of reporting in provincial and territo-
rial news bulletins and by Health Canada in the Canada
Communicable Diseases Report. 
In several instances over the past decade, malaria inci-
dence in Canada as a whole, or in individual provinces,
reached epidemic levels (7). Why some were not immedi-
ately identified and why no comprehensive analysis has
been published as part of government surveillance systems
are questions that will be addressed. Failing to recognize
these epidemics has limited the ability of public health
officials to assess and intervene appropriately to control
the illness and death associated with imported malaria in
Canada. 
This study evaluated and summarized data collected
over the past 22 years by local, provincial, and federal
malaria surveillance systems, from Canadian federal
immigration and refugee data resources and from interna-
tional tourist resources, to identify and explore the causes
of malaria epidemics. In addition, geographic patterns and
Plasmodium spp. profiles of malaria are examined. This
analysis led us to conclude that changes are needed in both
the surveillance reporting instruments and how these sur-
veillance results are analyzed and used.
Methods
The databases used for the present analysis include 22
years of records from a local malaria reference center in
Montreal, Canada (the McGill University Centre for
Tropical Diseases [TDC]) and up to 13 years of quality
assurance and notifiable disease surveillance databases  of
the provincial and federal governments of Canada, France,
India, Switzerland, the United States, and the United
Kingdom. TDC is a clinical and laboratory facility that
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(approximately 60% primary cases and 40% consult
cases), drawn mainly from the Montreal region. The TDC
database from 1981 to 2002 has allowed previous detailed
reviews of changing patterns of malaria in its patient pop-
ulations (8–10). Malaria-relevant data captured include
category of traveler (tourist, immigrant, refugee, expatri-
ate, missionary, and volunteer), countries visited, and
malaria species. A diagnosis of malaria is made if para-
sites are noted on a blood smear (thin, thick, or buffy
coat) or if, in the last 5 years, the patient had a positive
result on a malaria antigen-capture test (e.g., Macromed
[Nova Century Scientific, Inc., Burlington, Ontario,
Canada], ICT Malaria P.f. [ICT Diagnostics, Brookvale,
New South Wales, Australia], or OptiMAL [Flow Inc.,
Portland, OR]). While active surveillance studies during
this period included polymerase chain reaction (PCR) as
a screening tool, PCR-positive cases were not included in
any of the passive surveillance statistics unless they were
also independently confirmed by either malaria antigen
capture or smear. 
Provincial reportable disease databases have included,
in the past 10 years, patient characteristics such as age,
sex, and malaria species, but not the likely country of
acquisition. Because 90% of all malaria cases in Canada
were reported by the Provinces of British Columbia
(Monica Naus [British Columbia Centre for Disease
Control], pers. comm.), Ontario (Lorraine Schiedel
[Ontario Ministry of Health and Long-Term Care], pers.
comm.), and Québec (Colette Colin [Ministère de la santé
et des services sociaux, Québec], pers. comm.), the present
analysis focuses on their data, primarily for 1990–2002
(11). Quality assurance data for the province of Québec
(1994–2002) were provided by TDC and the Laboratoire
de Santé Publique du Québec. The federal government’s
notifiable disease database from 1990 to 2002 is a compi-
lation of selected information from individual provincial
databases and includes patient age and sex for each report
but no malaria species or country of acquisition (Carole
Scott [Division of Disease Surveillance, Health Canada],
pers. comm.).
International malaria surveillance data (1990–2002)
were acquired from the World Health Organization (WHO)
Regional Office for South East Asia (Rakish Mani Rastogi,
pers. comm.), the WHO Regional Office for Europe (12),
and the United States (13–24). Malaria rates for all coun-
tries were based on population data of the U.S. Census
Bureau (25).
Trends in Canadian immigration and refugee data for
the years 1990–2002 were provided by Citizen and
Immigration, Canada (Karen Tremblett [Medical Services
Branch, Citizen and Immigration Canada], pers. comm.),
data on language by Statistics Canada (26), and travel pat-
terns of Canadians to the tropics by the World Tourism
Organization, Madrid (27).
Results
TDC Database
Overall, 553 clinical cases of malaria were seen at TDC
from 1981 to 2002, with some fluctuation over time but an
overall gradual increase (Figure 1). In these 553 cases, 562
microscopy diagnoses were made; Plasmodium falci-
parum 295 (52%), P. vivax 218 (39%), P. ovale 26 (5%), P.
malariae 16 (3%), and unknown species 7 (1%). Nine
(2%) of the clinical cases were mixed infections, involving
P. falciparum with either P. malariae or P. vivax. Seven
patients were seen two or three times with relapses of P.
vivax (recurrence >2 months later). The relative frequency
of species changed over time, with a gradual increase in
the proportion of P. falciparum cases from 20% to 30% in
the early 1980s to 60% to 70% in the 1990s and to 70% to
80% in the present decade (Figure 2). Over this 22-year
period, only one fatality occurred (3).
Sixty-one countries were identified as the most likely
sources of the malaria exposure. Sub-Saharan Africa was
the region where most patients contracted malaria, 353
case-patients (65%), followed by south Asia (23%),
Southeast Asia (6%), Central America (5%), and South
America (1%). However, India, with 110 cases (20%), was
the single most frequent source country. Tourists (29%),
immigrants or refugees (29%), and foreign workers (24%)
represented the categories most frequently reported. Ashift
over time occurred in the importance of sub-Saharan Africa
as a source of malaria cases. In the 1980s, 50% of malaria
infections were acquired in Africa; in the 90s, 70%; and,
since 2000, 85%. Patients of all categories were more like-
ly to contract P. falciparum in Africa (74.3%) while it has
been an uncommon species in south Asia (5.8%). The
increase in P. falciparum cases over time correlated with
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Figure 1. McGill University Centre for Tropical Diseases malaria
cases by year and origin (N = 553).the increase in the total number of malaria cases contracted
in Africa; P. falciparum represented ≈30% of all cases in
the early 1980s and increased to 70% in the late 1990s.
From 1981 to 2002, 96% of malaria infections acquired in
south Asia were non-falciparum malarias, while only 29%
of infections from Africa were non-falciparum. None of the
553 cases of malaria originated from China, Malaysia,
Saudi Arabia, Peru, or Venezuela, which are frequent trav-
el destinations of Québecers. Other common travel destina-
tions contributed little to the 20-year malaria case total
(e.g., Philippines [1 case], South Africa [1], Costa Rica [2],
Mexico [2], and Dominican Republic [3]). Malaria cases
from Africa from 1992 to 2000 came predominantly (69%)
from the French-speaking African countries, notably high-
er than the proportion of U.S. travelers (18%) who acquired
malaria in these countries (13–24). 
Two “epidemics” were observed at TDC during this
period (Figures 1 and 2). The first was in 1986 to 1990 and
resulted from increasing numbers of P. falciparum infec-
tions from Africa, thought to be due to increasing chloro-
quine-resistant P. falciparum in chloroquine-prophylaxed
travelers (28), and the second was in 1999 through 2000,
resulting from increased numbers of P. falciparum infec-
tions associated with the arrival in Québec of large num-
bers of refugees from Tanzanian refugee camps (29). Both
epidemics were recognized and reported in the literature
soon after their appearance.
Federal and Provincial Databases
A review of the Federal Health Canada databases for
the incidence of malaria in Canada, from 1990 through
2002, documents a range from 364 to 1,029 cases per year,
with an average of 538 cases per year during the period (or
an average of ≈1.8 cases per 100,000 population per year)
(6) (Carole Scott [Division of Disease Surveillance, Health
Canada], pers. comm.). 
While all ages were affected, patients were mostly
adults from 20 to 59 years of age. A similar pattern of
malaria incidence was observed in males and females.
British Columbia had the highest rate per 100,000 (3.6 ±
2.8) over this period, followed by Ontario (2.2 ± 0.98), and
Québec (1.3 ± 0.67) (Figure 3). However, the highest
cumulative numbers for the 12-year period were reported
from Ontario (N = 3,222), followed by British Columbia
(N = 1,763), and Québec (N = 1,246). The Canadian data
suggest that an epidemic occurred from 1995 to 1997,
reflecting higher than average numbers of malaria cases in
these years from British Columbia, Ontario, and to a less-
er extent, from Québec (Figure 3). This epidemic was
almost entirely due to increased P. vivax being reported in
these provinces (Figure 4). From 1990 to 1999, two events
occurred in Québec that did not occur in other Canadian
provinces. In 1994, a quality assurance program for the
province was initiated by TDC, in collaboration with the
Laboratoire de Santé Publique du Québec. This three-
pronged program provided: 1) a free, rapid turnaround
confirmation service for positive or equivocal malaria
diagnoses from any laboratory in Québec, 2) a biannual
malaria-training course for clinical laboratory technolo-
gists, and 3) a voluntary proficiency testing program for
Québec hospital laboratories, in which once or twice a year
they are sent unknown positive and negative smears for
identification and receive extensive feedback. From the
inception of the quality assurance program, a parallel
increase was seen in numbers of specimens being sent to
the reference laboratory and to the Québec surveillance
program (Figure 5). This fourfold increase represented an
epidemic attributable to improved diagnosis and reporting.
The second event in Québec was another epidemic, in this
case of falciparum malaria, observed in 2000 to 2001 and
associated with a large influx of refugees from Tanzanian
refugee camps (Figure 4) (29).
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Figure 2. Relative rates of Plasmodium species (N = 553).
Figure 3. Provincial malaria rates for Québec, Ontario, and British
Columbia (6,11, Colette Colin [Ministère de la santé et des servic-
es sociaux, Québec], pers. comm.; Lorraine Schiedel [Ontario
Ministry of Health and Long Term Care], pers. comm.; Monica
Naus [British Columbia Centre for Disease Control], pers. comm.;
Carole Scott [Division of Disease Surveillance, Health Canada],
pers. comm.).International Malaria Surveillance
National surveillance systems for malaria are far from
universal, and compliance with national surveillance
instruments, when measured, is low. The stability of the
degree of underreporting over time has been not been eval-
uated. Despite these limitations, trends in malaria inci-
dence over time in different countries can provide useful
information. From 1995 to 1997, when parts of Canada
were having malaria epidemics, similar but smaller
changes in malaria rates were observed in the United
States and United Kingdom (Figure 6). An examination of
the geographic origin of malaria cases reported in the
United States in the mid-1990s showed a more than
twofold increase in malaria cases imported from India in
1995 through 1997, with an abrupt drop in these cases in
1998 (12–23). During this same period, a similar epidem-
ic of P. vivax malaria occurred in certain states in India
known to have important immigration and travel links with
North America (Figure 7). During the 1990s, France had a
60% increase in malaria in the latter part of the decade
(31), reportedly caused by African travel, and Denmark
experienced an increase of 68%; Germany, Italy, Spain,
Sweden, the Netherlands, and Belgium, however, had sta-
ble rates during this time (12,31). None of these countries
had the increase in rates of malaria seen in Canada and, to
a lesser degree, in the United States from 1995 to 1997.
Discussion
Malaria importations into Canada can occur by either
immigration or travel, and changing malaria attack rates in
the countries of exposure are likely to influence the inci-
dence of imported disease. Changes in Canadian immigra-
tion and refugee patterns from 1990 to 2002 are notable for
a threefold increase in annual immigrant numbers from the
Indian subcontinent and relatively stable numbers from
sub-Saharan Africa. Neither combined nor separate
provincial immigration and refugee patterns explain the
important swings in annual Canadian malaria rates. 
While the geographic origins of immigrants and
refugees do not immediately explain the epidemic changes
in P. vivax malaria seen in the mid-1990s, their nonrandom
aggregation in certain provinces allows additional insights.
African immigrants and refugees have settled all across
Canada in every province in numbers that paralleled the
province’s population. Immigrants and refugees from the
Indian subcontinent did not: 84% settled in Ontario and
British Columbia, the provinces with the most pronounced
P. vivax epidemics. Canadian travelers to malaria-endemic
areas have gradually but steadily increased during the past
15 years, most notably with a threefold increase to
Southeast Asia and Central and South America, a twofold
increase to the important malarial region of south Asia, and
a smaller increase to Africa. Travel patterns did not offer
an explanation for either the P. vivax epidemics in British
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Figure 4. Plasmodium species provincial trends (6,11, Colette
Colin [Ministère de la santé et des services sociaux, Québec],
pers. comm.; Monica Naus [British Columbia Centre for Disease
Control], pers. comm.; Lorraine Schiedel [Ontario Ministry of
Health and Long Term Care], pers. comm.). 
Figure 5. Malaria surveillance of Québec province, McGill Centre
for Tropical Diseases (TDC), and Québec quality assurance (QA)
program (Colette Colin [Ministère de la santé et des services soci-
aux, Québec], pers. comm.).Columbia and Ontario in the late 1990s or the P. falci-
parum epidemic in Québec from 2000 to 2001. The World
Tourism Organization data do not break down Canadian
travel by traveler’s province of origin; however, compar-
ing U.S. malaria surveillance data with TDC surveillance
data, both of which track the likely country of origin of a
malaria case, Québec travelers acquire most African
malaria in French-speaking African countries (69%), a
minor source of malaria for Americans (18%). English-
speaking Ontario and British Columbia likely have more
“American” travel patterns than francophone Québecers.
However, no fluctuations were seen in rates of travel to
either East or West Africa or to the Indian subcontinent, the
major source of Canada-acquired P. vivax malaria, which
would explain the impressive change in Canadian malaria
reporting from 1995 through 1997.
The two surveillance sources of India and the United
States were also reviewed for malaria incidence trends.
American malaria surveillance includes the likely country
of origin of a malaria case. An obvious increase in P. vivax
cases from India was seen in the United States, from 150
cases to 371 and down to 123, during 1995 to 1997. This
increase paralleled the epidemic peak seen in Canada, pri-
marily in Ontario and British Columbia. In India, an epi-
demic of P. vivax malaria occurred during this same period
(1995–1997) in the Punjabi states of Punjab and Haryana
(Figure 7). With negligible changes in travel destination or
immigration numbers to explain the 1995–1997 epidemic
in Canada, the explanation is probably an increased P.
vivax attack rate in Canadians traveling to the Punjab,
where a P. vivax epidemic occurred and ended at the same
time as the Canadian epidemic.
Canadian notifiable diseases surveillance data generat-
ed by local, provincial, and federal sources provided evi-
dence for the occurrence of two as-yet unreported malaria
epidemics in Canada in the last decade. One was a P. vivax
epidemic, the epicenter of which was almost certainly in
the Punjab, India. The second was a P. falciparum epidem-
ic in Québec related to an increased influx of Central
African refugees from Tanzanian refugee camps. At the
time, neither of these epidemics was brought to the atten-
tion of health practitioners in travel clinics through publi-
cation or other standard channels. Consequently, possible
explanations and potential interventions were not dis-
cussed.
Trends in immigration do not explain the malaria inci-
dence changes seen in Canada. These trends differ for each
province both in terms of country of origin and numbers.
However, the major fluctuations in federal and provincial
malaria rates from 1990 to 2002, and, in particular, during
the epidemic years, were not found to be directly linked to
provincial immigration numbers or to the travel destina-
tions of Canadians in general. Unfortunately, no mecha-
nism records the destinations of travelers from specific
provinces. Ontario and British Columbia are home to 86%
of the Punjabi-speaking Canadian population. If provincial
travel destination data were available, it would likely show
that these provinces were the source of most Canadian
travelers to the Indian Punjab (27).
Working back from individual case data in each
province seems to be the most accurate way to identify
countries where large numbers of imported malaria may
originate. Country of likely origin of the malaria should be
indicated on all requisitions for malaria laboratory diagno-
sis, and this information and the malaria species should be
reported to provincial and then federal surveillance bodies.
The fact that the 1995–1997 epidemic was primarily due to
P. vivax, the predominant malaria species in India, and that
it occurred at the same time as the P. vivax epidemic in the
Indian Punjabi states of Punjab and Haryana, is strong evi-
dence to conclude that the Canadian epidemic was
an extension of the Punjab epidemic. This association is
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Figure 6. Malaria cases/100,000 relative to 1990 (6,12–25,30,
Carole Scott [Division of Disease Surveillance, Health Canada],
pers. comm.).
Figure 7. Plasmodium vivax incidence relative to 1998 (6,11,
Colette Colin [Ministère de la santé et des services sociaux,
Québec], pers comm.; Monica Naus [British Columbia Centre for
Disease Control], pers. comm.).supported by the abrupt halt of both Canadian and Punjabi
epidemics in the same year. 
The surveillance process for notifiable diseases in
Canada and in other countries where malaria is now an
imported disease should be reviewed. Specific conditions,
such as the frequency of analysis of surveillance data, need
to be discussed and agreed on by collectors of these data at
each level of government. Without a firm plan in place for
analysis and dissemination of results, the validity, not to
mention the utility of the entire surveillance system, is
placed in jeopardy. One approach could be the American
emerging infections programs, a link between public
health, academic, and clinical communities (32).
For surveillance data to be useful and cost-effective, it
must be both available in a timely fashion and interpretable.
Local surveillance systems have obvious benefits when
increased water- and foodborne infections or vaccine-pre-
ventable diseases lead to quick public health action.
Malaria surveillance differs in two major ways from these
classical scenarios. Malaria is an imported disease, and no
immediate intervention (e.g., vaccine, chemical disinfec-
tant, and handwashing) will affect an epidemic. As with
sexually transmitted infections, the control of a malaria epi-
demic in Canadian travelers requires public education. In
the United States, both malaria speciation and country of
likely acquisition of the malaria case are part of surveil-
lance. Such information, if part of the Canadian system,
would allow rapid appreciation of the etiology of epidemics
such as those reviewed here, which would potentially lead
to appropriate public health response. 
Dr. MacLean is professor of medicine and director of the
McGill University Centre for Tropical Diseases. His research
interests are parasitic disease outbreak investigation (trichinosis,
Metorchis infections, and malaria) and the development of diag-
nostic tests for the clinical parasitology laboratory.
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